Skip to main content
SpringerLink
Log in

Selection of patients for intravesical therapy for superficial bladder cancer

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

In a nonrandomized retrospective study, 133 patients with superficial transitional cell carcinoma of the bladder were evaluated to identify any clinical prognostic features which indicate the necessity of intravesical therapy (IVT). The risk factors taken into account were stage, grade and multiplicity of the tumour. All patients were treated initially by complete transurethral resection (TUR), 27 patients received no further treatment after resection of the tumour 106 patients received adjuvant IVT over a period of 6 weeks. The mean follow-up was 23 and 18.8 months in the TUR-only group and TUR+IVT group, respectively. In the TUR-only group 7 and in the TUR+IVT group 29 recurrences were encountered. Patient group with no risk factors (Ta, GI, solitary tumour) or with only one risk factor revealed no statistical difference in terms of the recurrence rate from the identical control groups. So it does not seem worthwhile to give additional therapy in the low-risk groups. Another notable outcome of this study was that the higher the potential risk factors, the higher the likelihood of recurrence. The results suggest that T1 tumours, multifocal tumours, and high-grade tumours have poor prognosis, making additional treatment necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Flamm, J., Havelec, L.: Factors affecting survival in primary superficial bladder cancer.Eur. Urol. 17, 113 (1990).

    PubMed  CAS  Google Scholar 

  2. Herr, H. W.: Intravesical therapy: A critical review.Urol. Clin. North. Am. 14, 399 (1987).

    PubMed  CAS  Google Scholar 

  3. De Kernion, J. B., Huang, M. Y., Lindner, A., Smith, R. B., Kaufman, J. J.: The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guérin.J. Urol 133, 598 (1985).

    Google Scholar 

  4. Shapiro A., Ratliff, T. L., Oakley, D. M., Catalona, W. J.: Comparison of the efficacy of intravesical bacillus Calmette-Guérin with thiotepa, mitomycin C, poly: I:C/poly-L-lysine and cis platinum in murine bladder cancer.J. Urol. 131, 139 (1984).

    PubMed  CAS  Google Scholar 

  5. Pansadoro, V., De Paula, F.: Intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder.J. Urol. 138, 299 (1987).

    PubMed  CAS  Google Scholar 

  6. Soloway, M. S.: Evaluation and management of patients with superficial bladder cancer.Urol. Clin. North Am. 14, 771 (1987).

    PubMed  CAS  Google Scholar 

  7. Soloway, M. S.: Intravesical and systemic chemotherapy in the management of superficial bladder cancer.Urol. Clin. North. Am. 11, 623 (1984).

    PubMed  CAS  Google Scholar 

  8. Catalona, W. J.: Urothelial tumors of the urinary tract. In: Walsh, P. C., Retik, A. B., Stamey, T. A., Vaughan, E. D. (eds): Campbell's Urology. Saunders. Philadelphia 1992.

    Google Scholar 

  9. Mostofi, F. K., Sobin, L. H., Torloni, H.: Histological typing of urinary bladder tumors (International Histologic Classification of Tumors, No. 10). World Health Organization, Geneva 1973.

    Google Scholar 

  10. Lipponen, P. K., Eskelinen M. J., Kiviranta, J., Pesonen, E.: Prognosis of transitional cell bladder cancer. A multivariate prognostic score for improved prediction.J. Urol., 146, 1535 (1991).

    PubMed  CAS  Google Scholar 

  11. Lipponen, P. K., Collan, Y., Eskelinen, M. J., Pesonen, E., Sotarauta, M., Nordling, S.: Comparison of morphometry and DNA flow cytometry with standard prognostic factors in bladder cancer.Br. J. Urol. 65, 589 (1990).

    PubMed  CAS  Google Scholar 

  12. Lipponen, P. K., Collan, Y., Eskelinen, M. J., Pesonen, E., Sotarauta, M.: Morphometry in human transitional cell bladder cancer. Nuclear area and standard deviation of nuclear area relation to tumor grade (WHO) and prognosis.Eur. Urol. 17, 155 (1990).

    PubMed  CAS  Google Scholar 

  13. Kurth, K. H., Schröder, F. H., Tunn, U., Ay, R., Pavonen-Macaluso, M., Debruyne, F., De Pauw, M., Dalesio, O., Ten Kate, F.: Member of the European Organisation for Research on Treatment of Cancer, Genitourinary Tract Cancer Cooperative Group: Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: Preliminary results of a European Organisation for Research on Treatment of Cancer randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone.J. Urol. 132, 258 (1984).

    PubMed  CAS  Google Scholar 

  14. England, H. R., Paris, A. M. I., Blandy, J. P.: The correlation of T1 bladder tumour history with prognosis and follow-up requirements.Br. J. Urol. 53, 593 (1981).

    Article  PubMed  CAS  Google Scholar 

  15. Jordan, A. M., Weingarten, J., Murphy, W. M.: Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading?.Cancer, 60, 2766 (1987).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Ankara University, Ibn-i Sina Hospital, Ankara, Turkey

    Y. Bedük, L. S. Yaman, S. Baltaci, Y. Z. Müftüoĝlu, T. Yurdakul & O. Göĝüş

Authors
  1. Y. Bedük
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. S. Yaman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Baltaci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. Z. Müftüoĝlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Yurdakul
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O. Göĝüş
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bedük, Y., Yaman, L.S., Baltaci, S. et al. Selection of patients for intravesical therapy for superficial bladder cancer. International Urology and Nephrology 26, 523–528 (1994). https://doi.org/10.1007/BF02767653

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02767653

Keywords

Search

Navigation